Horseradish Peroxidase Market Summary
The Global Horseradish Peroxidase Market is projected to grow significantly from 1.81 USD Billion in 2024 to 4.47 USD Billion by 2035.
Key Market Trends & Highlights
Horseradish Peroxidase Key Trends and Highlights
- The market is expected to experience a compound annual growth rate (CAGR) of 8.56% from 2025 to 2035.
- By 2035, the market valuation is anticipated to reach 4.47 USD Billion, indicating robust growth potential.
- in 2024, the market is valued at 1.81 USD Billion, reflecting a solid foundation for future expansion.
- Growing adoption of horseradish peroxidase in various applications due to its effectiveness as a biocatalyst is a major market driver.
Market Size & Forecast
| 2024 Market Size | 1.81 (USD Billion) |
| 2035 Market Size | 4.47 (USD Billion) |
| CAGR (2025-2035) | 8.59% |
Major Players
GE Healthcare, Novus Biologicals, neweraR System, Thermo Fisher Scientific, Sigma-Aldrich, Promega Corporation, BioRad Laboratories, Agilent Technologies, Santa Cruz Biotechnology, Enzo Life Sciences, Abcam, Cayman Chemical, Cell Signaling Technology, BioTechne Corporation, Merck
Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review